These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1356741)

  • 21. Comparative biotransformation of triflubazam in rats, dogs, and monkeys.
    Alton KB; Patrick JE; Shaw C; McGuire JL
    Drug Metab Dispos; 1975; 3(6):445-52. PubMed ID: 1219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans.
    Scatina JA; Wells DS; Kimmel HB; Kemper CJ; Sisenwine SF
    Drug Metab Dispos; 1990; 18(5):746-52. PubMed ID: 1981731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism of femoxetine.
    Larsson H; Lund J
    Acta Pharmacol Toxicol (Copenh); 1981 May; 48(5):424-32. PubMed ID: 7336958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of p-(cyclopropylcarbonyl)phenylacetic acid (SQ 20,650). Species Differences.
    Lan SJ; El-Hawey AM; Dean AV; Schreiber EC
    Drug Metab Dispos; 1975; 3(3):171-9. PubMed ID: 238816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
    Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
    Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism of methylphenidate in dog and rat.
    Egger H; Bartlett F; Dreyfuss R; Karliner J
    Drug Metab Dispos; 1981; 9(5):415-23. PubMed ID: 6117439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and identification of urinary metabolites of porfiromycin in dogs and humans.
    Lang W; Mao J; Doyle TW; Almassian B
    Drug Metab Dispos; 2000 Aug; 28(8):899-904. PubMed ID: 10901698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
    Prakash C; Kamel A; Gummerus J; Wilner K
    Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disposition of a series of tetrahydrocarbazoles.
    Edelson J; Benziger DP
    Drug Metab Rev; 1980; 11(2):263-89. PubMed ID: 7011760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disposition and metabolism of the angiotensin-converting enzyme inhibitor [4S-[4 alpha, 7 alpha, (R*), 12b beta]]-7-[S-(1-ethoxycarbonyl-3- phenylpropyl)amino]-1,2,3,4,6,7,8,12b-octahydro-6-oxo- pyrido[2,1-a][2]benzazepine-4-carboxylic acid in monkeys and dogs.
    Cheng H; Stuhler JD; Dorrbecker BR; Gordon WP
    Drug Metab Dispos; 1991; 19(1):212-7. PubMed ID: 1673401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man.
    Zacchei AG; Weidner LL; Besselaar GH; Raftery EB
    Drug Metab Dispos; 1976; 4(4):387-401. PubMed ID: 8295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics, metabolism, and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in rats and rhesus monkeys.
    Tan EY; Hartmann G; Chen Q; Pereira A; Bradley S; Doss G; Zhang AS; Ho JZ; Braun MP; Dean DC; Tang W; Kumar S
    Drug Metab Dispos; 2010 Mar; 38(3):459-73. PubMed ID: 20016052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative theobromine metabolism in five mammalian species.
    Miller GE; Radulovic LL; DeWit RH; Brabec MJ; Tarka SM; Cornish HH
    Drug Metab Dispos; 1984; 12(2):154-60. PubMed ID: 6144479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolism of chlorpromazine N-oxide in man and dog.
    Jaworski TJ; Hawes EM; McKay G; Midha KK
    Xenobiotica; 1990 Jan; 20(1):107-15. PubMed ID: 2327102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition and biotransformation of quinpirole, a new D-2 dopamine agonist antihypertensive agent, in mice, rats, dogs, and monkeys.
    Whitaker NG; Lindstrom TD
    Drug Metab Dispos; 1987; 15(1):107-13. PubMed ID: 2881745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary metabolites of (R),(R)-labetalol.
    Alton KB; Chan TM; Pramanik BN
    Drug Metab Dispos; 1994; 22(6):866-72. PubMed ID: 7895603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
    Timchalk C; Nolan RJ
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of bepridil in laboratory animals and humans.
    Wu WN; Hills JF; Chang SY; Ng KT
    Drug Metab Dispos; 1988; 16(1):69-77. PubMed ID: 2894958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Species differences in the metabolism and disposition of spironolactone.
    Karim A; Kook C; Zitzewitz DJ; Zagarella J; Doherty M; Campion J
    Drug Metab Dispos; 1976; 4(6):547-55. PubMed ID: 11976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.